Skip to main content
Erschienen in: Journal of Neurology 12/2019

07.09.2019 | Original Communication

Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey

verfasst von: Franco Granella, Elena Tsantes, Stefania Graziuso, Veronica Bazzurri, Girolamo Crisi, Erica Curti

Erschienen in: Journal of Neurology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Spinal cord (SC) involvement correlates with poor prognosis in patients with multiple sclerosis (MS). Nevertheless, there is no consensus on the use of SC-MRI at follow-up, mainly because of the belief that SC lesions are nearly always symptomatic.

Objectives

The aim of the present study was to investigate the frequency of asymptomatic SC combined unique activity (CUA, new/enlarging T2 or gadolinium-positive [Gd+] lesions) on MRI in a cohort of patients diagnosed with clinically isolated syndrome (CIS) or relapsing–remitting MS (RRMS).

Methods

We retrospectively investigated all scans showing SC-CUA in patients with CIS or RRMS referred to a single Italian MS centre. We determined whether they were symptomatic and whether they had associated brain radiological activity.

Results

In 340 SC-MRI scans with SC-CUA (230 patients), SC-CUA was asymptomatic in 31.2%; 12.1% of SC-CUA had neither clinical activity nor brain radiological activity (44.5% and 25.4%, respectively, considering only follow-up SC-CUA). At multivariate analysis asymptomatic SC-CUAs were associated with older age at onset (34.0 ± 10.37 vs 31.0 ± 9.99 years, p = 0.006), non-spinal onset (76.4 vs 47.4%, p < 0.001), lower EDSS score at MRI (1.8 ± 0.93 vs 2.4 ± 1.28, p = 0.001) and lower number of Gd+ SC lesions (0.1 ± 0.33 vs 0.3 ± 0.54, p = 0.04), compared to symptomatic SC-CUAs.

Conclusions

A substantial proportion of our patients had SC-CUA without clinical symptoms and/or without concomitant brain MRI activity. In these patients, SC-CUA was the only sign of disease activity, suggesting that regular SC-MRI follow-up is required for reliable assessment of radiological activity and may improve the management of patients with MS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kearney H, Miller DH, Ciccarelli O (2015) Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value. Nat Rev Neurol 11:327–338CrossRef Kearney H, Miller DH, Ciccarelli O (2015) Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value. Nat Rev Neurol 11:327–338CrossRef
2.
Zurück zum Zitat Muccilli A, Seyman E, Oh J (2018) Spinal cord MRI in multiple sclerosis. Neurol Clin 36:35–57CrossRef Muccilli A, Seyman E, Oh J (2018) Spinal cord MRI in multiple sclerosis. Neurol Clin 36:35–57CrossRef
3.
Zurück zum Zitat Arrambide G, Rovira A, Sastre-Garriga J et al (2018) Spinal cord lesions: a modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler 24:301–312CrossRef Arrambide G, Rovira A, Sastre-Garriga J et al (2018) Spinal cord lesions: a modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler 24:301–312CrossRef
4.
Zurück zum Zitat Brownlee WJ, Altmann DR, Alves Da Mota P et al (2017) Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler 23:665–674CrossRef Brownlee WJ, Altmann DR, Alves Da Mota P et al (2017) Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler 23:665–674CrossRef
5.
Zurück zum Zitat Sombekke MH, Wattjes MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75CrossRef Sombekke MH, Wattjes MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75CrossRef
6.
Zurück zum Zitat Okuda DT, Mowry EM, Cree BA et al (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76:686–692CrossRef Okuda DT, Mowry EM, Cree BA et al (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76:686–692CrossRef
7.
Zurück zum Zitat Filippi M, Rocca MA, Ciccarelli O et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guideline. Lancet Neurol 15:292–303CrossRef Filippi M, Rocca MA, Ciccarelli O et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guideline. Lancet Neurol 15:292–303CrossRef
8.
Zurück zum Zitat Traboulsee A, Simon JH, Stone L et al (2016) Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 37:394–401CrossRef Traboulsee A, Simon JH, Stone L et al (2016) Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 37:394–401CrossRef
9.
Zurück zum Zitat Sormani MP, Bruzzi P (2013) MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol 12:669–676CrossRef Sormani MP, Bruzzi P (2013) MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol 12:669–676CrossRef
10.
Zurück zum Zitat Wattjes MP, Rovira À, Miller D et al (2015) Evidence based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606PubMed Wattjes MP, Rovira À, Miller D et al (2015) Evidence based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606PubMed
11.
Zurück zum Zitat Cortese R, Ciccarelli O (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—yes. Mult Scler 24:1536–1537CrossRef Cortese R, Ciccarelli O (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—yes. Mult Scler 24:1536–1537CrossRef
12.
Zurück zum Zitat Kearney H (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—no. Mult Scler 24:1537–1539CrossRef Kearney H (2018) Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging—no. Mult Scler 24:1537–1539CrossRef
13.
Zurück zum Zitat Zecca C, Disanto G, Sormani MP et al (2016) Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis. Mult Scler 22:782–791CrossRef Zecca C, Disanto G, Sormani MP et al (2016) Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis. Mult Scler 22:782–791CrossRef
14.
Zurück zum Zitat Thorpe JW, Kidd D, Moseley IF et al (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119:709–714CrossRef Thorpe JW, Kidd D, Moseley IF et al (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 119:709–714CrossRef
15.
Zurück zum Zitat Ruggieri S, Logoteta A, Tinelli E et al (2018) Measuring disease activity in multiple sclerosis: the essential role of spinal cord MRI monitoring. ECTRIMS Online Library. Ruggieri S 2018; 228465 (P621) Ruggieri S, Logoteta A, Tinelli E et al (2018) Measuring disease activity in multiple sclerosis: the essential role of spinal cord MRI monitoring. ECTRIMS Online Library. Ruggieri S 2018; 228465 (P621)
16.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRef
17.
Zurück zum Zitat Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286CrossRef Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286CrossRef
18.
Zurück zum Zitat Filippi M, Rocca MA, Bastianello S et al (2013) Guidelines from the Italian neurological and neuroradiological societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol Sci 34:2085–2093CrossRef Filippi M, Rocca MA, Bastianello S et al (2013) Guidelines from the Italian neurological and neuroradiological societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol Sci 34:2085–2093CrossRef
19.
Zurück zum Zitat Sormani MP, Gasperini C, Romeo M et al (2016) Assessing response to interferon-b in a multicenter dataset of patients with MS. Neurology 87:134–140CrossRef Sormani MP, Gasperini C, Romeo M et al (2016) Assessing response to interferon-b in a multicenter dataset of patients with MS. Neurology 87:134–140CrossRef
20.
Zurück zum Zitat Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3:27–39 Eckstein C, Syc S, Saidha S (2011) Differential diagnosis of longitudinally extensive transverse myelitis in adults. Eur Neurol J 3:27–39
Metadaten
Titel
Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey
verfasst von
Franco Granella
Elena Tsantes
Stefania Graziuso
Veronica Bazzurri
Girolamo Crisi
Erica Curti
Publikationsdatum
07.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 12/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09526-3

Weitere Artikel der Ausgabe 12/2019

Journal of Neurology 12/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.